Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Westat
- Study ID
- NCT07438041
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- HIV
- PrEP
- PrEP Adherence
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 24 Years
- Healthy Volunteers
- Accepted
Interventions
- LYPS — OTHERThe LYPS intervention combines the use of a CHP to deliver PrEP services at a designated place in the community being offered by the SC where PrEP is not yet provided (e.g., participant's home, community partner location, or traveling mobile van) with an android-based smartphone or iphone app to support PrEP use between CHP visits.
- Enhanced Standard of Care — OTHERClinic-based PrEP services per usual standard of care (e.g., HIV and STI testing, clinical assessments for signs and symptoms of HIV and PrEP safety) with access to a limited number of LYPS app components, including basic PrEP adherence information and study visit reminders.
Study Details
The LYPS intervention is a multi-level intervention that combines: a) structural-level delivery of PrEP and PrEP services by a community health professional (CHP) at a designated place in the community being offered by the SC where PrEP is not yet provided (e.g., participant's home, community partner location, or traveling mobile van), with b) an individual-level mobile application (app) to support PrEP adherence and persistence between CHP visits.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Mar 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 272 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: LYPS InterventionPrEP and PrEP care will be delivered to youth in the communities where they live through a Community Health Professional (CHP) (e.g., a nurse or other qualified health care professional home, friend's home, community venue or clinic, mobile health clinic), supplemented by a mobile app to provide real-time intervention between CHP visits.
- Active Comparator: Enhanced Standard of Care (eSOC) Control ConditionUsual standard of care clinic-based PrEP, enhanced with access to a limited number of LYPS app components, including basic PrEP adherence information and study visit reminders.
Primary Outcome Measure
PrEP adherence at 6 months [ Time Frame: 6 months ]
Central Contacts
- Nancy Liu718-980-3937
- Erin Ricketts240-453-2786
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| San Francisco Department of Public Health | San Francisco | California | 94102 | Albert Liu (PRINCIPAL_INVESTIGATOR) |
| Emory Atlanta Adolescent Consortium | Atlanta | Georgia | 30322 | Andres Camacho-Gonzalez (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins University | Baltimore | Maryland | 21287 | Allison Agwu (PRINCIPAL_INVESTIGATOR) |
| Baylor College of Medicine | Houston | Texas | 77030 | Mary Paul (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
Related Studies
- Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Washington D.C., District of Columbia
- Viral Load in Blood and Lymph Tissues in People Living With HIVRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressorsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland